TrialBlood advances2021

IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial.

Rachel J Mitchell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.